Literature DB >> 14678454

Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.

Sung-Gon Kim1, Byeung-Deuk Han, Je-Min Park, Myung-Jung Kim, Michael F Stromberg.   

Abstract

Both naltrexone and acamprosate have been utilized clinically in recovering alcoholics with varying success. In the experiment reported here the combination of naltrexone and acamprosate was examined in a limited access alcohol model using C57BL/6 mice to determine if there was evidence of additive or synergistic effects. The results of this experiment demonstrate that naltrexone, at the higher dose but not the lower dose, significantly reduced alcohol consumption. When combined with naltrexone, acamprosate reduced alcohol consumption across both doses of naltrexone. This effect was sensitive to both dose and number of days of exposure to the naltrexone/acamprosate combination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678454     DOI: 10.1111/j.1440-1819.2004.01189.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  9 in total

1.  Effects of cannabidiol plus naltrexone on motivation and ethanol consumption.

Authors:  Adrián Viudez-Martínez; María S García-Gutiérrez; Ana Isabel Fraguas-Sánchez; Ana Isabel Torres-Suárez; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

Review 2.  Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date.

Authors:  Mary R Lee; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

3.  Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat.

Authors:  Terril L Verplaetse; Cristine L Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2015-03-07       Impact factor: 4.530

4.  High Drinking in the Dark (HDID) mice are sensitive to the effects of some clinically relevant drugs to reduce binge-like drinking.

Authors:  John C Crabbe; Angela R Ozburn; Pamela Metten; Amanda Barkley-Levenson; Jason P Schlumbohm; Stephanie E Spence; Wyatt R Hack; Lawrence C Huang
Journal:  Pharmacol Biochem Behav       Date:  2017-08-05       Impact factor: 3.533

5.  Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats.

Authors:  Ronnie Dhaher; Jamie E Toalston; Sheketha R Hauser; Richard L Bell; David L McKinzie; William J McBride; Zachary A Rodd
Journal:  Alcohol       Date:  2011-10-01       Impact factor: 2.405

6.  The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.

Authors:  Catherine F Moore; Omar A Protzuk; Bankole A Johnson; Wendy J Lynch
Journal:  Pharmacol Biochem Behav       Date:  2013-11-16       Impact factor: 3.533

7.  Effects of naltrexone on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J mice.

Authors:  Arthur Tomie; Idu Azogu; Lei Yu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-13       Impact factor: 5.067

8.  Zonisamide decreases ethanol intake in rats and mice.

Authors:  Clifford M Knapp; Melissa Mercado; Tara Lynn Markley; Steven Crosby; Domenic A Ciraulo; Conan Kornetsky
Journal:  Pharmacol Biochem Behav       Date:  2007-04-11       Impact factor: 3.533

9.  Evaluation of acute effects of melatonin on ethanol drinking in ethanol naïve rats.

Authors:  Zahoor Ahmad Rather; Mukta N Chowta; Ganaraja Bolumbu; K B Rakesh
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.